Literature DB >> 2934993

Altered phospholipid metabolism in pressure-overload hypertrophied hearts.

D K Reibel, B O'Rourke, K A Foster, H Hutchinson, C E Uboh, R L Kent.   

Abstract

The content and fatty acyl composition of phospholipids were examined in pressure-overload hypertrophied hearts. Cardiac hypertrophy was induced in rats by abdominal aortic constriction. Twenty-one days postconstriction the content of myocardial phosphatidylcholine (PC), sphingomyelin, and phosphatidylinositol (PI) was significantly elevated by 10, 10, and 20%, respectively. The essential fatty acid, linoleic acid, was markedly reduced in PC, phosphatidylethanolamine (PE), PI, and cardiolipin (CL) of hypertrophied hearts. The associated changes in fatty acyl composition were specific for the individual phospholipid class as evidenced by a significant elevation of palmitic acid in PC, docosahexaenoic acid in PE and oleic acid in CL. Alterations in fatty acyl composition of phospholipids were associated with no change in the composition of cardiac triglycerides, cardiac free fatty acids or serum lipids. The fatty acyl composition of phospholipids was also altered in pressure-overload hypertrophied hearts of cats, as evidenced by a reduction of linoleic acid and an elevation of arachidonic acid in total phospholipids. These findings demonstrate that changes in phospholipid metabolism occur in the pressure-overloaded mammalian heart. Such alterations may contribute to altered membrane function in the hypertrophied myocardium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2934993     DOI: 10.1152/ajpheart.1986.250.1.H1

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.

Authors:  Meghan S Soustek; Darin J Falk; Cathryn S Mah; Matthew J Toth; Michael Schlame; Alfred S Lewin; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

2.  Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.

Authors:  Brian E Sansbury; Angelica M DeMartino; Zhengzhi Xie; Alan C Brooks; Robert E Brainard; Lewis J Watson; Andrew P DeFilippis; Timothy D Cummins; Matthew A Harbeson; Kenneth R Brittian; Sumanth D Prabhu; Aruni Bhatnagar; Steven P Jones; Bradford G Hill
Journal:  Circ Heart Fail       Date:  2014-04-24       Impact factor: 8.790

3.  Endothelial control of lower limb blood flow in chronic heart failure.

Authors:  D C Lindsay; D R Holdright; D Clarke; I S Anand; P A Poole-Wilson; P Collins
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 4.  Selective updates on mechanisms of action of positive inotropic agents.

Authors:  G Grupp
Journal:  Mol Cell Biochem       Date:  1987-08       Impact factor: 3.396

5.  Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice.

Authors:  Bernard P C Kok; Petra C Kienesberger; Jason R B Dyck; David N Brindley
Journal:  J Lipid Res       Date:  2011-11-05       Impact factor: 5.922

6.  Chronic hypoxia alters fatty acid composition of phospholipids in right and left ventricular myocardium.

Authors:  Jana Jezková; Olga Nováková; Frantisek Kolár; Eva Tvrzická; Jan Neckár; Frantisek Novák
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

7.  Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets.

Authors:  Adam J Chicco; Genevieve C Sparagna; Sylvia A McCune; Christopher A Johnson; Robert C Murphy; David A Bolden; Meredith L Rees; Ryan T Gardner; Russell L Moore
Journal:  Hypertension       Date:  2008-07-28       Impact factor: 10.190

8.  Alterations in heart and kidney membrane phospholipids in hypertension as observed by 31P nuclear magnetic resonance.

Authors:  Y Chi; R K Gupta
Journal:  Lipids       Date:  1998-10       Impact factor: 1.880

9.  Effect of hypo- and hyperthyroid states on phospholipid composition in developing rat heart.

Authors:  Blanka Hamplová; Olga Nováková; Eva Tvrzická; Václav Pelouch; Frantisek Novák
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

10.  Emergence of Orai3 activity during cardiac hypertrophy.

Authors:  Youakim Saliba; Mathilde Keck; Alexandre Marchand; Fabrice Atassi; Aude Ouillé; Olivier Cazorla; Mohamed Trebak; Catherine Pavoine; Alain Lacampagne; Jean-Sébastien Hulot; Nassim Farès; Jérémy Fauconnier; Anne-Marie Lompré
Journal:  Cardiovasc Res       Date:  2014-09-11       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.